Get the Stockscreener App
2.96
2.63%
-0.08
After Hours:
2.96
Abvc Biopharma Inc stock is traded at $2.96, with a volume of 53,847.
It is down -2.63% in the last 24 hours and up +3.86% over the past month.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$3.04
Open:
$3.06
24h Volume:
53,847
Relative Volume:
0.30
Market Cap:
$69.68M
Revenue:
$152.40K
Net Income/Loss:
$-10.52M
P/E Ratio:
-1.1873
EPS:
-2.4931
Net Cash Flow:
$-4.26M
1W Performance:
-5.43%
1M Performance:
+3.86%
6M Performance:
+223.85%
1Y Performance:
+527.12%
1-Day Range:
$2.93
$3.1596
1-Week Range:
$2.93
$3.40
52-Week Range:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Name
Abvc Biopharma Inc
Sector
Industry
Phone
510-668-0881
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
2.96 | 71.57M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abvc Biopharma Inc Stock (ABVC) Latest News
How to build a custom watchlist for ABVC BioPharma Inc.2025 Earnings Impact & Fast Gaining Stock Reports - newser.com
How resilient is ABVC BioPharma Inc. stock in market downturnsIPO Watch & Fast Moving Market Watchlists - newser.com
When is the best time to exit ABVC BioPharma Inc.2025 Market Overview & Real-Time Buy Signal Notifications - newser.com
Why analysts upgrade ABVC BioPharma Inc. stock2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
How geopolitical tensions affect ABVC BioPharma Inc. stockPrice Action & Safe Investment Capital Preservation Plans - newser.com
Evaluating ABVC BioPharma Inc. with trendline analysisDay Trade & Free Weekly Watchlist of Top Performers - newser.com
Can ABVC BioPharma Inc. stock maintain growth trajectoryEarnings Beat & Daily Technical Stock Forecast Reports - newser.com
Analyzing recovery setups for ABVC BioPharma Inc. investorsQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - newser.com
Multi asset correlation models including ABVC BioPharma Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - newser.com
What momentum shifts mean for ABVC BioPharma Inc.2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for ABVC BioPharma (NASDAQ:ABVC) - MarketBeat
ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus(R) Production - Yahoo Finance
What does recent volatility data suggest for ABVC BioPharma Inc.Earnings Recap Summary & Community Supported Trade Ideas - newser.com
Is ABVC BioPharma Inc. stock safe for conservative investors2025 Key Highlights & Technical Pattern Based Signals - newser.com
Should you hold or exit ABVC BioPharma Inc. nowMarket Trend Summary & Daily Technical Forecast Reports - newser.com
How strong is ABVC BioPharma Inc. stock balance sheetWeekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com
ABVC BioPharma (NASDAQ:ABVC) Shares Down 1.3% – Here’s Why - Defense World
ABVC BioPharma (NASDAQ:ABVC) Shares Down 1.3%Here's Why - MarketBeat
ABVC BioPharma Inc Stock Analysis and ForecastMarket Sentiment Shifts & Big Profit Low Investment - earlytimes.in
What analysts say about ABVC BioPharma Inc stockStraddle and Strangle Trades & These Picks Are Just One Breakout Away - earlytimes.in
Abvc Biopharma Inc Stock (ABVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):